HARBOUR INVESTMENTS, INC. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,654
-8.3%
600.0%0.00%
Q2 2023$1,804
-44.7%
60
-33.3%
0.00%
Q1 2023$3,261
+1.6%
900.0%0.00%
Q4 2022$3,210
-19.8%
90
-26.2%
0.00%
Q3 2022$4,0000.0%1220.0%0.00%
Q2 2022$4,0000.0%1220.0%0.00%
Q4 2021$4,000
+33.3%
1220.0%0.00%
Q3 2021$3,000
-78.6%
122
-73.8%
0.00%
Q2 2021$14,000
+16.7%
465
+2.6%
0.00%
Q1 2021$12,0004530.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders